Related Experiment Video
Updated: Aug 9, 2026
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Ras signaling in prostate cancer progression
Michael J Weber1, Daniel Gioeli
1Department of Microbiology and Cancer Center, University of Virginia Health System, Charlottesville, Virginia 22908, USA. mjw@virginia.edu
Journal of Cellular Biochemistry
|December 23, 2003
Summary
Prostate cancer often becomes androgen-independent (AI) but still requires the androgen receptor (AR). Growth factors and Ras signaling may drive AI prostate cancer by making the AR hypersensitive to low androgen levels.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate cancer initially depends on androgens but often recurs as androgen-independent (AI) disease.
- AI prostate cancer is typically fatal and still requires the androgen receptor (AR) for growth.
- Understanding how the AR functions in AI prostate cancer is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the mechanisms by which the androgen receptor (AR) remains active in androgen-independent (AI) prostate cancer.
- To explore the role of growth factors, receptors, and Ras signaling in prostate cancer progression to AI disease.
- To examine the potential involvement of post-translational modifications in modulating AR activity.
Main Methods:
- The study proposes a mechanistic hypothesis based on existing evidence.
- It focuses on the interplay between growth factor signaling pathways (Ras family) and the androgen receptor (AR).
- It suggests investigating post-translational modifications of transcriptional cofactors.
Main Results:
- The article posits that growth factors and Ras signaling pathways drive prostate cancer progression towards androgen hypersensitivity.
- It suggests that post-translational modifications, such as phosphorylations, of transcriptional cofactors may enable AR function at low androgen concentrations.
- This leads to a state where the AR is active even without sufficient physiological levels of androgens.
Conclusions:
- Growth factor signaling and Ras pathways are implicated in the progression of prostate cancer to an androgen-independent state.
- Post-translational modifications of cofactors are proposed as a key mechanism for maintaining AR activity in AI prostate cancer.
- Further research into these pathways could reveal novel therapeutic targets for hormone-refractory prostate cancer.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...